Estrogen receptor-positive breast cancer (ER+) happens when high levels of estrogen in breast cancer cells help cancer grow and spread. Finding out if cancerous cells have estrogen or progesterone receptors helps healthcare providers plan breast cancer treatment. Providers often treat ER+ breast cancer with surgery and hormone therapy.
ER-positive breast cancer (ER+) is a breast cancer subtype. If tests show you have estrogen receptor-positive breast cancer, it means cancerous cells in your breast have high estrogen levels helping them to grow. Checking estrogen receptor levels helps healthcare providers to plan treatment. Healthcare providers treat this condition with surgery and hormone therapy.
This breast cancer subtype is also known as estrogen-positive breast cancer and estrogen receptor-positive breast cancer.
It’s relatively common. About 70% of all breast cancer cases — including men and people assigned male at birth (AMAB) — in the United States are ER-positive.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
People with ER-positive breast cancer typically have common breast cancer symptoms, including:
Cells in your body have hormone receptors. The hormone receptors are a type of protein. Estrogen in your bloodstream can attach to the receptors. This hormone-receptor process is part of typical body function. In healthy cells, estrogen aids normal cell function and growth.
ER-positive breast cancer occurs when estrogen connects with proteins inside cancer cells, causing the cells to grow. It may also happen when estrogen and another hormone, progesterone, connect with proteins inside cancer cells. Breast cancer with high progesterone levels is PR-positive breast cancer.
The overarching risk for women and people assigned female at birth AFAB is long-term exposure to estrogen. Risks for men and people AMAB are linked to situations where they have more estrogen and less testosterone than usual (hormonal imbalance).
Risk factors for women and people AFAB include:
Risk factors for men and people AMAB include:
Advertisement
Your healthcare provider does a breast biopsy to obtain samples of cancer tumor tissue. They send the samples to a lab. There, a medical pathologist tests tissue for signs of hormone receptors. A hormone receptor-positive (HR+) result means estrogen, progesterone or both hormones are fueling cancer growth. If tests don’t find high estrogen levels, the breast cancer is considered estrogen receptor-negative (ER-negative).
Healthcare providers may treat ER-positive breast cancer with:
Common chemotherapy and radiation therapy side effects include fatigue, nausea and vomiting. Common hormone therapy side effects may include:
If you’re receiving ER-positive breast cancer treatment, ask your healthcare provider about palliative care. This care may help you manage breast cancer symptoms and treatment side effects.
Advertisement
Data from the National Cancer Institute (NCI) show that overall, more than 90% of women and people AFAB were alive five years after diagnosis. NCI data doesn’t break out ER-positive survival rates for men and people AMAB.
When you think about survival rates, it’s important to remember these rates are based on the experiences of large groups of people with the same condition. More than that, these are estimates based on what was going on during a specific time that may be years in the past. If you have questions about survival rates, ask your healthcare provider what you can expect.
While this breast cancer type is considered to be less aggressive, there’s a risk of recurrence after treatment, including treatment for early-stage, low-risk ER-positive breast cancer. If you’re concerned that breast cancer will come back, ask your oncologist about your individual risk and what you can do to reduce your risk.
If you have ER-positive breast cancer, the following suggestions may be helpful:
Contact your provider if your symptoms seem to be getting worse or if you have new symptoms, like pain or weakness in a different part of your body.
You may want to ask the following questions:
Estrogen receptor-positive breast (ER+) cancer is powered by estrogen, a hormone that helps cells to grow. Healthcare providers check breast cancer cells for estrogen levels and plan treatment accordingly, such as hormone treatment that reduces estrogen’s impact on cancerous cells. If you have ER+ breast cancer, ask your healthcare provider to explain treatment options and how each treatment may help.
Last reviewed on 01/24/2024.
Learn more about the Health Library and our editorial process.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy